Skip to content

To evaluate the Keratex Oil for hair growth, hair density and overall improvement in hair & scalp condition in healthy human subjects

Evaluation of the Keratex Oil for hair growth, hair density and overall improvement in hair & scalp condition in healthy human subjects

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/09/007275
Enrollment
76
Registered
2016-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Keratex Oil: The oil is multiple herbal and natural oil preparation to be tested for efficacy and safety in 8 weeks study.The oil has to be applied topically over hair and scalp.The Qua

Sponsors

Dabur India Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Male and female subjectsâ?? in general good health. • Subjects in the age group 18-55 years (both the ages inclusive). • Subjects willing to give a written informed consent and agree to come for a regular follow up visit. • Female and Male Subjects falling under Grade 3 - Grade 8 of hair loss severity grade evaluated as per standard photo numeric 10 point scale • Subjects willing to abide by and comply with the study protocol. • Subjects who have not participated in a similar investigation in the past two weeks. • Subjects complaining of hair fall and damage. • Healthy volunteers with no known allergy as established by medical history. • Subjects who are not on crash dieting. • Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration. • Literate subjects only.

Exclusion criteria

Exclusion criteria: • Subjects who are undergoing hair growth treatment within 3 months before screening into the study. • Subjects having any active scalp disease which may interfere in the study. • Subjects who have treatments of cancer chemotherapy last 6 months before starting study or have a plan to do treatments of them during study terms. • Subjects who have history of alcoholism and/ or psychiatric disorder including trichotillomania. • Subjects who have had hair transplant. • Subjects who take pharmaceutical product which cause hirsutism (ex. phenytoin) and finesteride for androgenic alopecia. • A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products. • Subjects on oral medications which will compromise the study. • Subjects who are pregnant or lactating or nursing as established with medical history. • Chronic illness which may influence the cutaneous state. • Subjects participating in other similar cosmetic or therapeutic trial within last two weeks • Subject having history of migraine headache.

Design outcomes

Primary

MeasureTime frame
â?¢ To evaluate the efficacy of Keratex Oil in hair growth in comparison to baseline and control. â?¢ To evaluate the efficacy of Keratex Oil in hair density in comparison to baseline and control.Timepoint: 8 Weeks

Secondary

MeasureTime frame
Safety of Investigational product by assessment of site application reaction by dermatologist and subjects.Timepoint: 8 weeks

Countries

India

Contacts

Public ContactRitambhara

Dabur India Ltd

arun.gupta@dabur.com01203378614

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026